30 results on '"Conibear J"'
Search Results
2. The National Lung Cancer Audit: The Impact of COVID-19.
Catalog
Books, media, physical & digital resources
3. MO-0392 Inter-observer variation in a national lung SABR rollout program: Lessons learnt & future directions
4. The ALK project: a real-world national network and database
5. EP-1862: Consider the radiation dose to the kidneys during Intensity Modulated breast cancer treatment
6. OC-0421: Consistency of organs at risk delineation guidance in UK radiotherapy clinical trials
7. 105 - The role of physical optimisation ‘pre-hab’ in lung cancer patients with advanced stage disease
8. 119: SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial
9. 62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England
10. P166 - Do residual radionuclides following the Chernobyl accident lead to a distinct subtype of breast cancer?
11. A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy.
12. Dose-modified XELIRI Chemotherapy for Metastatic Colorectal Cancer — A Retrospective Study of 78 Patients.
13. 127 Outcome of CyberKnife radiosurgery for early stage lung cancer.
14. A Novel Method of Optimising the CTV to PTV Margin in Prostate Radiotherapy using Fiducials and Strict Organ Filling.
15. 145: Retrospective review of survival outcomes for non-small cell lung cancer (NSCLC) patients treated with radical radiotherapy since 2000 in St. Bartholomew's Hospital, London.
16. PD-0421: Brachytherapy planning techniques for cervical cancer as part of the INTERLACE Trial.
17. Multicenter Assessment of Autocontouring Using Deformable Image Registration for Adaptive Therapy.
18. PD-0266: A survey of UK practice in cervical cancer radiotherapy aimed at developing trial specific quality assurance.
19. PO-0684: Assessment of target volume contour variability within a UK multicentre lung radiotherapy trial.
20. PD-0317: Field-based and volume-based PTV as plan evaluation structures in the UK FAST-Forward breast trial.
21. PO-0937: Impact of quality assurance on contour conformity within two UK head & neck radiotherapy trials.
22. 1171MO AI-derived diagnostic criteria for early lung cancer screening using primary care health records.
23. UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy.
24. Personal View: Low-dose Lung Radiotherapy for COVID-19 Pneumonia – The Atypical Science and the Unknown Collateral Consequence.
25. Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials.
26. PO-0643: Volumetric versus anatomical outlining: target delineation conformity in a multi-centre head and neck trial.
27. 1166P Social determinants of lung cancer in East London.
28. EP-1768: De-ESCALaTE HPV radiotherapy quality assurance: Improving plan quality within a UK HNC trial.
29. Multicenter Clinical Assessment of DIR Atlas-Based Autocontouring.
30. 1379P Real-world (RW) clinical outcomes of patients with metastatic non-small cell lung cancer (mNSCLC) in the United Kingdom.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.